Suchergebnisse - "Shah, Rashmi R"

PubPharm (147)

21

Nonclinical cardiovascular safety of pitolisant : comparing International Conference on Harmonization S7B and Comprehensive in vitro Pro-arrhythmia Assay initiative studies

enthalten in: British journal of pharmacology | 2017

von Ligneau, X. | Shah, R. | Berrebi-Bertrand, I. | +7

22

Importance of Publishing Adverse Drug Reaction Case Reports : Promoting Public Health and Advancing Pharmacology and Therapeutics

enthalten in: Drug safety - case reports | 2017

von Shah, R.

23

Importance of Publishing Adverse Drug Reaction Case Reports: Promoting Public Health and Advancing Pharmacology and Therapeutics

enthalten in: Drug safety - case reports | 2017

von Shah, R.

24

Pharmacogenetics and precision medicine : Is inflammation a covert threat to effective genotype-based therapy?

enthalten in: Therapeutic advances in drug safety | 2017

von Shah, R.

25

Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome : Could Hypomagnesaemia Be the Trigger?

enthalten in: Drug safety | 2017

von Shah, R.

26

Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?

enthalten in: Medical toxicology | 2017

von Shah, R.

27

Hyperglycaemia Induced by Novel Anticancer Agents : An Undesirable Complication or a Potential Therapeutic Opportunity?

enthalten in: Drug safety | 2017

von Shah, R.

28

Hyperglycaemia Induced by Novel Anticancer Agents: An Undesirable Complication or a Potential Therapeutic Opportunity?

enthalten in: Medical toxicology | 2017

von Shah, R.

29

Comment on : Bono P, Oudard S, Bodrogi I, et al. Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials. Clin Genitourin Cancer 2016

enthalten in: Clinical genitourinary cancer | 2017

von Shah, R.

CommentOn: Clin Genitourin Cancer. 2016 Oct;14(5):406-414. - PMID 27287020

30

Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?

enthalten in: Drug safety | 2017

von Shah, R.